3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Nasopharyngeal Carcinoma
6
Oropharyngeal Neoplasms
5
Prostatic Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma
4
Mouth Neoplasms
3
Hypopharyngeal Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mesothelioma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced Cervical Adenocarcinoma
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
Specimen Handling
33
Magnetic Resonance Spectroscopy
29
Pemetrexed
27
Carboplatin
27
pembrolizumab
26
Cisplatin
22
Paclitaxel
13
durvalumab
12
Nivolumab
11
Gemcitabine
11
Docetaxel
10
osimertinib
9
Radiosurgery
9
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
Ramucirumab
6
Radiotherapy
6
Etoposide
6
Biopsy
6
atezolizumab
5
Radiation
5
Platinum
5
Irinotecan
5
Albumin-Bound Paclitaxel
5
Observation
4
Ipilimumab
4
Cetuximab
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.